nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—breast cancer—bone cancer	0.155	1	CtDrD
Idarubicin—Epirubicin—bone cancer	0.133	0.519	CrCtD
Idarubicin—Doxorubicin—bone cancer	0.123	0.481	CrCtD
Idarubicin—Anthracyclines—Epirubicin—bone cancer	0.107	0.341	CiPCiCtD
Idarubicin—Anthracyclines—Doxorubicin—bone cancer	0.0992	0.316	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Epirubicin—bone cancer	0.0561	0.178	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Doxorubicin—bone cancer	0.0519	0.165	CiPCiCtD
Idarubicin—TOP2A—Epirubicin—bone cancer	0.0289	0.352	CbGbCtD
Idarubicin—Daunorubicin—Epirubicin—bone cancer	0.0285	0.173	CrCrCtD
Idarubicin—Doxorubicin—Epirubicin—bone cancer	0.0285	0.173	CrCrCtD
Idarubicin—Valrubicin—Epirubicin—bone cancer	0.0285	0.173	CrCrCtD
Idarubicin—Daunorubicin—Doxorubicin—bone cancer	0.0264	0.16	CrCrCtD
Idarubicin—Valrubicin—Doxorubicin—bone cancer	0.0264	0.16	CrCrCtD
Idarubicin—Epirubicin—Doxorubicin—bone cancer	0.0264	0.16	CrCrCtD
Idarubicin—ABCC1—Epirubicin—bone cancer	0.016	0.195	CbGbCtD
Idarubicin—TOP2A—Doxorubicin—bone cancer	0.0154	0.187	CbGbCtD
Idarubicin—ABCC1—Doxorubicin—bone cancer	0.00851	0.104	CbGbCtD
Idarubicin—ABCC1—Methotrexate—bone cancer	0.00825	0.1	CbGbCtD
Idarubicin—CYP2C9—Cisplatin—bone cancer	0.00316	0.0385	CbGbCtD
Idarubicin—CYP2D6—Doxorubicin—bone cancer	0.00194	0.0236	CbGbCtD
Idarubicin—TOP2A—Gastric Cancer Network 1—C21orf33—bone cancer	0.00066	0.167	CbGpPWpGaD
Idarubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.000381	0.0966	CbGpPWpGaD
Idarubicin—Recall phenomenon—Epirubicin—bone cancer	0.00033	0.0142	CcSEcCtD
Idarubicin—Gastrointestinal toxicity—Doxorubicin—bone cancer	0.000323	0.0139	CcSEcCtD
Idarubicin—Radiation recall reaction (dermatologic)—Doxorubicin—bone cancer	0.000323	0.0139	CcSEcCtD
Idarubicin—Phlebitis—Carboplatin—bone cancer	0.00032	0.0138	CcSEcCtD
Idarubicin—Tachyarrhythmia—Epirubicin—bone cancer	0.000313	0.0135	CcSEcCtD
Idarubicin—Recall phenomenon—Doxorubicin—bone cancer	0.000305	0.0131	CcSEcCtD
Idarubicin—Tachyarrhythmia—Doxorubicin—bone cancer	0.00029	0.0125	CcSEcCtD
Idarubicin—Myelodysplastic syndrome—Epirubicin—bone cancer	0.000285	0.0123	CcSEcCtD
Idarubicin—Septicemia—Methotrexate—bone cancer	0.000269	0.0116	CcSEcCtD
Idarubicin—Myelodysplastic syndrome—Doxorubicin—bone cancer	0.000264	0.0113	CcSEcCtD
Idarubicin—Alopecia reversible—Epirubicin—bone cancer	0.000252	0.0108	CcSEcCtD
Idarubicin—Septicemia—Epirubicin—bone cancer	0.000252	0.0108	CcSEcCtD
Idarubicin—Cardiotoxicity—Epirubicin—bone cancer	0.000243	0.0104	CcSEcCtD
Idarubicin—Myelosuppression—Cisplatin—bone cancer	0.000238	0.0102	CcSEcCtD
Idarubicin—Myocarditis—Epirubicin—bone cancer	0.000234	0.0101	CcSEcCtD
Idarubicin—Alopecia reversible—Doxorubicin—bone cancer	0.000233	0.01	CcSEcCtD
Idarubicin—Septicemia—Doxorubicin—bone cancer	0.000233	0.01	CcSEcCtD
Idarubicin—Leukaemia—Methotrexate—bone cancer	0.000227	0.00976	CcSEcCtD
Idarubicin—Cardiotoxicity—Doxorubicin—bone cancer	0.000225	0.00966	CcSEcCtD
Idarubicin—Myocarditis—Doxorubicin—bone cancer	0.000217	0.00932	CcSEcCtD
Idarubicin—Leukaemia—Epirubicin—bone cancer	0.000213	0.00913	CcSEcCtD
Idarubicin—Leukaemia—Doxorubicin—bone cancer	0.000197	0.00845	CcSEcCtD
Idarubicin—Septic shock—Epirubicin—bone cancer	0.00019	0.00814	CcSEcCtD
Idarubicin—Febrile neutropenia—Cisplatin—bone cancer	0.000185	0.00796	CcSEcCtD
Idarubicin—Thromboembolism—Epirubicin—bone cancer	0.00018	0.00773	CcSEcCtD
Idarubicin—Fluid overload—Cisplatin—bone cancer	0.000179	0.0077	CcSEcCtD
Idarubicin—Septic shock—Doxorubicin—bone cancer	0.000175	0.00754	CcSEcCtD
Idarubicin—Lymphoma—Methotrexate—bone cancer	0.000175	0.00752	CcSEcCtD
Idarubicin—Thromboembolism—Doxorubicin—bone cancer	0.000167	0.00716	CcSEcCtD
Idarubicin—ABCC1—Irinotecan Pathway—CYP3A4—bone cancer	0.000162	0.041	CbGpPWpGaD
Idarubicin—Sinus tachycardia—Epirubicin—bone cancer	0.000142	0.00611	CcSEcCtD
Idarubicin—Necrosis—Cisplatin—bone cancer	0.000142	0.0061	CcSEcCtD
Idarubicin—Pericarditis—Methotrexate—bone cancer	0.000141	0.00608	CcSEcCtD
Idarubicin—Infection—Carboplatin—bone cancer	0.000135	0.00579	CcSEcCtD
Idarubicin—Pericarditis—Epirubicin—bone cancer	0.000132	0.00569	CcSEcCtD
Idarubicin—Sinus tachycardia—Doxorubicin—bone cancer	0.000132	0.00565	CcSEcCtD
Idarubicin—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNA11—bone cancer	0.000129	0.0327	CbGpPWpGaD
Idarubicin—Extravasation—Cisplatin—bone cancer	0.000128	0.00549	CcSEcCtD
Idarubicin—Pericarditis—Doxorubicin—bone cancer	0.000122	0.00526	CcSEcCtD
Idarubicin—Myelosuppression—Epirubicin—bone cancer	0.000122	0.00524	CcSEcCtD
Idarubicin—Hyperuricaemia—Cisplatin—bone cancer	0.00012	0.00516	CcSEcCtD
Idarubicin—Ulcer—Cisplatin—bone cancer	0.000118	0.00506	CcSEcCtD
Idarubicin—Blood uric acid increased—Cisplatin—bone cancer	0.000114	0.00488	CcSEcCtD
Idarubicin—Embolism venous—Epirubicin—bone cancer	0.000113	0.00487	CcSEcCtD
Idarubicin—Bundle branch block—Epirubicin—bone cancer	0.000113	0.00487	CcSEcCtD
Idarubicin—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000113	0.0287	CbGpPWpGaD
Idarubicin—Myelosuppression—Doxorubicin—bone cancer	0.000113	0.00485	CcSEcCtD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000113	0.0286	CbGpPWpGaD
Idarubicin—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000112	0.0284	CbGpPWpGaD
Idarubicin—Cardiomyopathy—Epirubicin—bone cancer	0.000112	0.00481	CcSEcCtD
Idarubicin—TOP2A—Doxorubicin—Epirubicin—bone cancer	0.000112	0.26	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Epirubicin—bone cancer	0.000112	0.26	CbGdCrCtD
Idarubicin—Mucosal inflammation—Methotrexate—bone cancer	0.00011	0.00475	CcSEcCtD
Idarubicin—Body temperature increased—Carboplatin—bone cancer	0.000107	0.0046	CcSEcCtD
Idarubicin—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000107	0.0271	CbGpPWpGaD
Idarubicin—Bundle branch block—Doxorubicin—bone cancer	0.000105	0.00451	CcSEcCtD
Idarubicin—Embolism venous—Doxorubicin—bone cancer	0.000105	0.00451	CcSEcCtD
Idarubicin—Cardiomyopathy—Doxorubicin—bone cancer	0.000104	0.00445	CcSEcCtD
Idarubicin—Mucosal inflammation—Epirubicin—bone cancer	0.000103	0.00444	CcSEcCtD
Idarubicin—Local reaction—Epirubicin—bone cancer	0.000103	0.00444	CcSEcCtD
Idarubicin—TOP2A—Epirubicin—Doxorubicin—bone cancer	0.000103	0.24	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Doxorubicin—bone cancer	0.000103	0.24	CbGdCrCtD
Idarubicin—Skin hyperpigmentation—Methotrexate—bone cancer	0.000103	0.00442	CcSEcCtD
Idarubicin—Febrile neutropenia—Methotrexate—bone cancer	0.000102	0.00437	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Epirubicin—bone cancer	9.63e-05	0.00413	CcSEcCtD
Idarubicin—Mucosal inflammation—Doxorubicin—bone cancer	9.57e-05	0.00411	CcSEcCtD
Idarubicin—Local reaction—Doxorubicin—bone cancer	9.57e-05	0.00411	CcSEcCtD
Idarubicin—Embolism—Methotrexate—bone cancer	9.53e-05	0.00409	CcSEcCtD
Idarubicin—Febrile neutropenia—Epirubicin—bone cancer	9.52e-05	0.00409	CcSEcCtD
Idarubicin—Phlebitis—Cisplatin—bone cancer	9.39e-05	0.00404	CcSEcCtD
Idarubicin—Bone marrow depression—Methotrexate—bone cancer	9.06e-05	0.00389	CcSEcCtD
Idarubicin—TOP2A—Circadian rythm related genes—TNFRSF11A—bone cancer	9.03e-05	0.0229	CbGpPWpGaD
Idarubicin—Cardiac failure congestive—Cisplatin—bone cancer	8.92e-05	0.00383	CcSEcCtD
Idarubicin—Embolism—Epirubicin—bone cancer	8.92e-05	0.00383	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Doxorubicin—bone cancer	8.91e-05	0.00383	CcSEcCtD
Idarubicin—Burning sensation—Methotrexate—bone cancer	8.81e-05	0.00378	CcSEcCtD
Idarubicin—Febrile neutropenia—Doxorubicin—bone cancer	8.81e-05	0.00378	CcSEcCtD
Idarubicin—Bone marrow depression—Epirubicin—bone cancer	8.48e-05	0.00364	CcSEcCtD
Idarubicin—Embolism—Doxorubicin—bone cancer	8.25e-05	0.00354	CcSEcCtD
Idarubicin—Burning sensation—Epirubicin—bone cancer	8.24e-05	0.00354	CcSEcCtD
Idarubicin—Bone marrow depression—Doxorubicin—bone cancer	7.85e-05	0.00337	CcSEcCtD
Idarubicin—Necrosis—Methotrexate—bone cancer	7.79e-05	0.00335	CcSEcCtD
Idarubicin—Burning sensation—Doxorubicin—bone cancer	7.62e-05	0.00328	CcSEcCtD
Idarubicin—Dehydration—Cisplatin—bone cancer	7.53e-05	0.00323	CcSEcCtD
Idarubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	7.41e-05	0.0188	CbGpPWpGaD
Idarubicin—Necrosis—Epirubicin—bone cancer	7.29e-05	0.00313	CcSEcCtD
Idarubicin—Daunorubicin—CYP3A4—bone cancer	7.27e-05	0.552	CrCbGaD
Idarubicin—Extravasation—Methotrexate—bone cancer	7.01e-05	0.00301	CcSEcCtD
Idarubicin—Necrosis—Doxorubicin—bone cancer	6.75e-05	0.0029	CcSEcCtD
Idarubicin—Pancytopenia—Cisplatin—bone cancer	6.64e-05	0.00285	CcSEcCtD
Idarubicin—Hyperuricaemia—Methotrexate—bone cancer	6.59e-05	0.00283	CcSEcCtD
Idarubicin—Extravasation—Epirubicin—bone cancer	6.56e-05	0.00282	CcSEcCtD
Idarubicin—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	6.51e-05	0.0165	CbGpPWpGaD
Idarubicin—Ulcer—Methotrexate—bone cancer	6.47e-05	0.00278	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	6.39e-05	0.0162	CbGpPWpGaD
Idarubicin—Blood uric acid increased—Methotrexate—bone cancer	6.23e-05	0.00268	CcSEcCtD
Idarubicin—Hyperuricaemia—Epirubicin—bone cancer	6.17e-05	0.00265	CcSEcCtD
Idarubicin—Acute coronary syndrome—Cisplatin—bone cancer	6.15e-05	0.00264	CcSEcCtD
Idarubicin—Myocardial infarction—Cisplatin—bone cancer	6.11e-05	0.00263	CcSEcCtD
Idarubicin—Stomatitis—Cisplatin—bone cancer	6.08e-05	0.00261	CcSEcCtD
Idarubicin—Extravasation—Doxorubicin—bone cancer	6.07e-05	0.00261	CcSEcCtD
Idarubicin—Ulcer—Epirubicin—bone cancer	6.05e-05	0.0026	CcSEcCtD
Idarubicin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	6.05e-05	0.0153	CbGpPWpGaD
Idarubicin—Doxorubicin—CYP3A4—bone cancer	5.9e-05	0.448	CrCbGaD
Idarubicin—Atrioventricular block—Epirubicin—bone cancer	5.9e-05	0.00254	CcSEcCtD
Idarubicin—Blood uric acid increased—Epirubicin—bone cancer	5.83e-05	0.0025	CcSEcCtD
Idarubicin—Hyperuricaemia—Doxorubicin—bone cancer	5.71e-05	0.00245	CcSEcCtD
Idarubicin—ABCC1—S1P1 pathway—PTGS2—bone cancer	5.61e-05	0.0142	CbGpPWpGaD
Idarubicin—Ulcer—Doxorubicin—bone cancer	5.6e-05	0.00241	CcSEcCtD
Idarubicin—Neoplasm—Methotrexate—bone cancer	5.53e-05	0.00238	CcSEcCtD
Idarubicin—Urinary tract disorder—Cisplatin—bone cancer	5.53e-05	0.00237	CcSEcCtD
Idarubicin—Colitis—Epirubicin—bone cancer	5.5e-05	0.00236	CcSEcCtD
Idarubicin—Urethral disorder—Cisplatin—bone cancer	5.49e-05	0.00236	CcSEcCtD
Idarubicin—Atrioventricular block—Doxorubicin—bone cancer	5.46e-05	0.00235	CcSEcCtD
Idarubicin—CYP2D6—Xenobiotics—CYP3A4—bone cancer	5.45e-05	0.0138	CbGpPWpGaD
Idarubicin—CYP2C9—Xenobiotics—CYP3A4—bone cancer	5.4e-05	0.0137	CbGpPWpGaD
Idarubicin—Blood uric acid increased—Doxorubicin—bone cancer	5.39e-05	0.00232	CcSEcCtD
Idarubicin—Sepsis—Methotrexate—bone cancer	5.31e-05	0.00228	CcSEcCtD
Idarubicin—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	5.24e-05	0.0133	CbGpPWpGaD
Idarubicin—Oesophagitis—Epirubicin—bone cancer	5.23e-05	0.00225	CcSEcCtD
Idarubicin—Flushing—Cisplatin—bone cancer	5.2e-05	0.00223	CcSEcCtD
Idarubicin—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	5.19e-05	0.0132	CbGpPWpGaD
Idarubicin—Neoplasm—Epirubicin—bone cancer	5.18e-05	0.00222	CcSEcCtD
Idarubicin—Thrombophlebitis—Methotrexate—bone cancer	5.13e-05	0.0022	CcSEcCtD
Idarubicin—Colitis—Doxorubicin—bone cancer	5.09e-05	0.00218	CcSEcCtD
Idarubicin—Immune system disorder—Cisplatin—bone cancer	5.06e-05	0.00217	CcSEcCtD
Idarubicin—Arrhythmia—Cisplatin—bone cancer	5e-05	0.00215	CcSEcCtD
Idarubicin—Sepsis—Epirubicin—bone cancer	4.97e-05	0.00213	CcSEcCtD
Idarubicin—Alopecia—Cisplatin—bone cancer	4.95e-05	0.00213	CcSEcCtD
Idarubicin—Malnutrition—Cisplatin—bone cancer	4.87e-05	0.00209	CcSEcCtD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	4.86e-05	0.0123	CbGpPWpGaD
Idarubicin—Oesophagitis—Doxorubicin—bone cancer	4.84e-05	0.00208	CcSEcCtD
Idarubicin—Phlebitis—Epirubicin—bone cancer	4.82e-05	0.00207	CcSEcCtD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	4.82e-05	0.0122	CbGpPWpGaD
Idarubicin—Thrombophlebitis—Epirubicin—bone cancer	4.8e-05	0.00206	CcSEcCtD
Idarubicin—Neoplasm—Doxorubicin—bone cancer	4.79e-05	0.00206	CcSEcCtD
Idarubicin—Hepatic function abnormal—Epirubicin—bone cancer	4.76e-05	0.00204	CcSEcCtD
Idarubicin—Sepsis—Doxorubicin—bone cancer	4.6e-05	0.00197	CcSEcCtD
Idarubicin—Cardiac failure congestive—Epirubicin—bone cancer	4.58e-05	0.00197	CcSEcCtD
Idarubicin—Anaemia—Cisplatin—bone cancer	4.5e-05	0.00193	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—DHFR—bone cancer	4.5e-05	0.0114	CbGpPWpGaD
Idarubicin—Phlebitis—Doxorubicin—bone cancer	4.46e-05	0.00192	CcSEcCtD
Idarubicin—Hot flush—Epirubicin—bone cancer	4.44e-05	0.00191	CcSEcCtD
Idarubicin—Thrombophlebitis—Doxorubicin—bone cancer	4.44e-05	0.00191	CcSEcCtD
Idarubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	4.42e-05	0.0112	CbGpPWpGaD
Idarubicin—Menopausal symptoms—Epirubicin—bone cancer	4.4e-05	0.00189	CcSEcCtD
Idarubicin—Hepatic function abnormal—Doxorubicin—bone cancer	4.4e-05	0.00189	CcSEcCtD
Idarubicin—Leukopenia—Cisplatin—bone cancer	4.36e-05	0.00187	CcSEcCtD
Idarubicin—Cardiac failure congestive—Doxorubicin—bone cancer	4.24e-05	0.00182	CcSEcCtD
Idarubicin—Convulsion—Cisplatin—bone cancer	4.22e-05	0.00181	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	4.12e-05	0.00177	CcSEcCtD
Idarubicin—Hot flush—Doxorubicin—bone cancer	4.11e-05	0.00177	CcSEcCtD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	4.09e-05	0.0104	CbGpPWpGaD
Idarubicin—Menopausal symptoms—Doxorubicin—bone cancer	4.08e-05	0.00175	CcSEcCtD
Idarubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	4.07e-05	0.0103	CbGpPWpGaD
Idarubicin—Anaphylactic shock—Cisplatin—bone cancer	3.98e-05	0.00171	CcSEcCtD
Idarubicin—Infection—Cisplatin—bone cancer	3.95e-05	0.0017	CcSEcCtD
Idarubicin—Thrombocytopenia—Cisplatin—bone cancer	3.89e-05	0.00167	CcSEcCtD
Idarubicin—TOP2A—Gastric Cancer Network 2—EGFR—bone cancer	3.88e-05	0.00984	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—ZW10—bone cancer	3.87e-05	0.00981	CbGpPWpGaD
Idarubicin—Dehydration—Epirubicin—bone cancer	3.86e-05	0.00166	CcSEcCtD
Idarubicin—Skin disorder—Cisplatin—bone cancer	3.86e-05	0.00166	CcSEcCtD
Idarubicin—Anorexia—Cisplatin—bone cancer	3.79e-05	0.00163	CcSEcCtD
Idarubicin—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	3.71e-05	0.0094	CbGpPWpGaD
Idarubicin—Pancytopenia—Methotrexate—bone cancer	3.65e-05	0.00157	CcSEcCtD
Idarubicin—Neutropenia—Methotrexate—bone cancer	3.59e-05	0.00154	CcSEcCtD
Idarubicin—Dehydration—Doxorubicin—bone cancer	3.58e-05	0.00154	CcSEcCtD
Idarubicin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	3.53e-05	0.00895	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	3.48e-05	0.00882	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—ZW10—bone cancer	3.46e-05	0.00877	CbGpPWpGaD
Idarubicin—Decreased appetite—Cisplatin—bone cancer	3.46e-05	0.00149	CcSEcCtD
Idarubicin—Pancytopenia—Epirubicin—bone cancer	3.41e-05	0.00147	CcSEcCtD
Idarubicin—Neutropenia—Epirubicin—bone cancer	3.36e-05	0.00144	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	3.36e-05	0.00851	CbGpPWpGaD
Idarubicin—Stomatitis—Methotrexate—bone cancer	3.34e-05	0.00143	CcSEcCtD
Idarubicin—TOP2A—Gastric Cancer Network 2—TP53—bone cancer	3.26e-05	0.00826	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	3.17e-05	0.00803	CbGpPWpGaD
Idarubicin—Pancytopenia—Doxorubicin—bone cancer	3.16e-05	0.00136	CcSEcCtD
Idarubicin—Body temperature increased—Cisplatin—bone cancer	3.14e-05	0.00135	CcSEcCtD
Idarubicin—Stomatitis—Epirubicin—bone cancer	3.12e-05	0.00134	CcSEcCtD
Idarubicin—Neutropenia—Doxorubicin—bone cancer	3.11e-05	0.00133	CcSEcCtD
Idarubicin—Haemoglobin—Methotrexate—bone cancer	3.09e-05	0.00133	CcSEcCtD
Idarubicin—Haemorrhage—Methotrexate—bone cancer	3.07e-05	0.00132	CcSEcCtD
Idarubicin—TOP2A—Circadian rythm related genes—GNA11—bone cancer	3.06e-05	0.00775	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—EZH2—bone cancer	3.04e-05	0.00771	CbGpPWpGaD
Idarubicin—Urinary tract disorder—Methotrexate—bone cancer	3.03e-05	0.0013	CcSEcCtD
Idarubicin—Urethral disorder—Methotrexate—bone cancer	3.01e-05	0.00129	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle, Mitotic—TUBB4B—bone cancer	2.93e-05	0.00744	CbGpPWpGaD
Idarubicin—Hypersensitivity—Cisplatin—bone cancer	2.93e-05	0.00126	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—bone cancer	2.92e-05	0.0074	CbGpPWpGaD
Idarubicin—Haemoglobin—Epirubicin—bone cancer	2.89e-05	0.00124	CcSEcCtD
Idarubicin—Stomatitis—Doxorubicin—bone cancer	2.89e-05	0.00124	CcSEcCtD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	2.89e-05	0.00732	CbGpPWpGaD
Idarubicin—Haemorrhage—Epirubicin—bone cancer	2.88e-05	0.00123	CcSEcCtD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	2.85e-05	0.00722	CbGpPWpGaD
Idarubicin—Urinary tract disorder—Epirubicin—bone cancer	2.84e-05	0.00122	CcSEcCtD
Idarubicin—Urethral disorder—Epirubicin—bone cancer	2.82e-05	0.00121	CcSEcCtD
Idarubicin—Angiopathy—Methotrexate—bone cancer	2.79e-05	0.0012	CcSEcCtD
Idarubicin—Immune system disorder—Methotrexate—bone cancer	2.77e-05	0.00119	CcSEcCtD
Idarubicin—Chills—Methotrexate—bone cancer	2.76e-05	0.00118	CcSEcCtD
Idarubicin—Diarrhoea—Cisplatin—bone cancer	2.72e-05	0.00117	CcSEcCtD
Idarubicin—Alopecia—Methotrexate—bone cancer	2.71e-05	0.00117	CcSEcCtD
Idarubicin—Malnutrition—Methotrexate—bone cancer	2.67e-05	0.00115	CcSEcCtD
Idarubicin—Haemoglobin—Doxorubicin—bone cancer	2.67e-05	0.00115	CcSEcCtD
Idarubicin—Flushing—Epirubicin—bone cancer	2.67e-05	0.00115	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle, Mitotic—RFC1—bone cancer	2.66e-05	0.00674	CbGpPWpGaD
Idarubicin—Haemorrhage—Doxorubicin—bone cancer	2.66e-05	0.00114	CcSEcCtD
Idarubicin—Urinary tract disorder—Doxorubicin—bone cancer	2.63e-05	0.00113	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle—TUBB4B—bone cancer	2.62e-05	0.00665	CbGpPWpGaD
Idarubicin—Angiopathy—Epirubicin—bone cancer	2.61e-05	0.00112	CcSEcCtD
Idarubicin—Urethral disorder—Doxorubicin—bone cancer	2.61e-05	0.00112	CcSEcCtD
Idarubicin—Immune system disorder—Epirubicin—bone cancer	2.6e-05	0.00112	CcSEcCtD
Idarubicin—ABCC1—Arachidonic acid metabolism—PTGS2—bone cancer	2.59e-05	0.00656	CbGpPWpGaD
Idarubicin—Chills—Epirubicin—bone cancer	2.58e-05	0.00111	CcSEcCtD
Idarubicin—Arrhythmia—Epirubicin—bone cancer	2.57e-05	0.0011	CcSEcCtD
Idarubicin—Alopecia—Epirubicin—bone cancer	2.54e-05	0.00109	CcSEcCtD
Idarubicin—Vomiting—Cisplatin—bone cancer	2.53e-05	0.00109	CcSEcCtD
Idarubicin—Rash—Cisplatin—bone cancer	2.51e-05	0.00108	CcSEcCtD
Idarubicin—Dermatitis—Cisplatin—bone cancer	2.51e-05	0.00108	CcSEcCtD
Idarubicin—Malnutrition—Epirubicin—bone cancer	2.5e-05	0.00108	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	2.49e-05	0.00631	CbGpPWpGaD
Idarubicin—Anaemia—Methotrexate—bone cancer	2.47e-05	0.00106	CcSEcCtD
Idarubicin—Flushing—Doxorubicin—bone cancer	2.47e-05	0.00106	CcSEcCtD
Idarubicin—Angiopathy—Doxorubicin—bone cancer	2.41e-05	0.00104	CcSEcCtD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	2.41e-05	0.00612	CbGpPWpGaD
Idarubicin—Immune system disorder—Doxorubicin—bone cancer	2.4e-05	0.00103	CcSEcCtD
Idarubicin—Leukopenia—Methotrexate—bone cancer	2.39e-05	0.00103	CcSEcCtD
Idarubicin—Chills—Doxorubicin—bone cancer	2.39e-05	0.00103	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle—RFC1—bone cancer	2.38e-05	0.00603	CbGpPWpGaD
Idarubicin—Arrhythmia—Doxorubicin—bone cancer	2.38e-05	0.00102	CcSEcCtD
Idarubicin—Nausea—Cisplatin—bone cancer	2.36e-05	0.00101	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	2.36e-05	0.00599	CbGpPWpGaD
Idarubicin—Alopecia—Doxorubicin—bone cancer	2.35e-05	0.00101	CcSEcCtD
Idarubicin—Convulsion—Methotrexate—bone cancer	2.32e-05	0.000995	CcSEcCtD
Idarubicin—Malnutrition—Doxorubicin—bone cancer	2.32e-05	0.000995	CcSEcCtD
Idarubicin—Anaemia—Epirubicin—bone cancer	2.31e-05	0.000994	CcSEcCtD
Idarubicin—Chest pain—Methotrexate—bone cancer	2.28e-05	0.000978	CcSEcCtD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	2.26e-05	0.00573	CbGpPWpGaD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	2.26e-05	0.000971	CcSEcCtD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	2.24e-05	0.00568	CbGpPWpGaD
Idarubicin—Leukopenia—Epirubicin—bone cancer	2.24e-05	0.000962	CcSEcCtD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	2.23e-05	0.00566	CbGpPWpGaD
Idarubicin—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	2.21e-05	0.00561	CbGpPWpGaD
Idarubicin—Anaphylactic shock—Methotrexate—bone cancer	2.18e-05	0.000938	CcSEcCtD
Idarubicin—Convulsion—Epirubicin—bone cancer	2.17e-05	0.000931	CcSEcCtD
Idarubicin—Infection—Methotrexate—bone cancer	2.17e-05	0.000931	CcSEcCtD
Idarubicin—Anaemia—Doxorubicin—bone cancer	2.14e-05	0.000919	CcSEcCtD
Idarubicin—Thrombocytopenia—Methotrexate—bone cancer	2.14e-05	0.000918	CcSEcCtD
Idarubicin—Chest pain—Epirubicin—bone cancer	2.13e-05	0.000915	CcSEcCtD
Idarubicin—Skin disorder—Methotrexate—bone cancer	2.12e-05	0.000911	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	2.12e-05	0.000909	CcSEcCtD
Idarubicin—Anorexia—Methotrexate—bone cancer	2.08e-05	0.000894	CcSEcCtD
Idarubicin—Leukopenia—Doxorubicin—bone cancer	2.07e-05	0.00089	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	2.05e-05	0.00521	CbGpPWpGaD
Idarubicin—Anaphylactic shock—Epirubicin—bone cancer	2.04e-05	0.000877	CcSEcCtD
Idarubicin—Infection—Epirubicin—bone cancer	2.03e-05	0.000872	CcSEcCtD
Idarubicin—Shock—Epirubicin—bone cancer	2.01e-05	0.000863	CcSEcCtD
Idarubicin—Convulsion—Doxorubicin—bone cancer	2.01e-05	0.000862	CcSEcCtD
Idarubicin—Thrombocytopenia—Epirubicin—bone cancer	2e-05	0.000859	CcSEcCtD
Idarubicin—Skin disorder—Epirubicin—bone cancer	1.98e-05	0.000852	CcSEcCtD
Idarubicin—Chest pain—Doxorubicin—bone cancer	1.97e-05	0.000847	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	1.96e-05	0.000841	CcSEcCtD
Idarubicin—Anorexia—Epirubicin—bone cancer	1.95e-05	0.000836	CcSEcCtD
Idarubicin—Decreased appetite—Methotrexate—bone cancer	1.9e-05	0.000815	CcSEcCtD
Idarubicin—Anaphylactic shock—Doxorubicin—bone cancer	1.89e-05	0.000812	CcSEcCtD
Idarubicin—Infection—Doxorubicin—bone cancer	1.88e-05	0.000807	CcSEcCtD
Idarubicin—Shock—Doxorubicin—bone cancer	1.86e-05	0.000799	CcSEcCtD
Idarubicin—Thrombocytopenia—Doxorubicin—bone cancer	1.85e-05	0.000795	CcSEcCtD
Idarubicin—Skin disorder—Doxorubicin—bone cancer	1.84e-05	0.000789	CcSEcCtD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	1.83e-05	0.00465	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	1.82e-05	0.00461	CbGpPWpGaD
Idarubicin—Anorexia—Doxorubicin—bone cancer	1.8e-05	0.000774	CcSEcCtD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	1.79e-05	0.00454	CbGpPWpGaD
Idarubicin—Gastrointestinal pain—Methotrexate—bone cancer	1.78e-05	0.000767	CcSEcCtD
Idarubicin—Decreased appetite—Epirubicin—bone cancer	1.78e-05	0.000763	CcSEcCtD
Idarubicin—Urticaria—Methotrexate—bone cancer	1.73e-05	0.000745	CcSEcCtD
Idarubicin—Body temperature increased—Methotrexate—bone cancer	1.73e-05	0.000741	CcSEcCtD
Idarubicin—Abdominal pain—Methotrexate—bone cancer	1.73e-05	0.000741	CcSEcCtD
Idarubicin—TOP2A—Circadian rythm related genes—CDK4—bone cancer	1.72e-05	0.00435	CbGpPWpGaD
Idarubicin—Gastrointestinal pain—Epirubicin—bone cancer	1.67e-05	0.000717	CcSEcCtD
Idarubicin—ABCC1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.67e-05	0.00422	CbGpPWpGaD
Idarubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	1.66e-05	0.00421	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	1.65e-05	0.00418	CbGpPWpGaD
Idarubicin—Decreased appetite—Doxorubicin—bone cancer	1.64e-05	0.000706	CcSEcCtD
Idarubicin—Urticaria—Epirubicin—bone cancer	1.62e-05	0.000697	CcSEcCtD
Idarubicin—Body temperature increased—Epirubicin—bone cancer	1.61e-05	0.000694	CcSEcCtD
Idarubicin—Abdominal pain—Epirubicin—bone cancer	1.61e-05	0.000694	CcSEcCtD
Idarubicin—Hypersensitivity—Methotrexate—bone cancer	1.61e-05	0.000691	CcSEcCtD
Idarubicin—Gastrointestinal pain—Doxorubicin—bone cancer	1.55e-05	0.000664	CcSEcCtD
Idarubicin—Hypersensitivity—Epirubicin—bone cancer	1.5e-05	0.000646	CcSEcCtD
Idarubicin—Urticaria—Doxorubicin—bone cancer	1.5e-05	0.000645	CcSEcCtD
Idarubicin—Abdominal pain—Doxorubicin—bone cancer	1.49e-05	0.000642	CcSEcCtD
Idarubicin—Body temperature increased—Doxorubicin—bone cancer	1.49e-05	0.000642	CcSEcCtD
Idarubicin—Diarrhoea—Methotrexate—bone cancer	1.49e-05	0.000641	CcSEcCtD
Idarubicin—TOP2A—Cell Cycle—DHFR—bone cancer	1.47e-05	0.00374	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.44e-05	0.00364	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	1.43e-05	0.00362	CbGpPWpGaD
Idarubicin—Diarrhoea—Epirubicin—bone cancer	1.4e-05	0.0006	CcSEcCtD
Idarubicin—Hypersensitivity—Doxorubicin—bone cancer	1.39e-05	0.000598	CcSEcCtD
Idarubicin—Vomiting—Methotrexate—bone cancer	1.39e-05	0.000596	CcSEcCtD
Idarubicin—Rash—Methotrexate—bone cancer	1.38e-05	0.000591	CcSEcCtD
Idarubicin—Dermatitis—Methotrexate—bone cancer	1.37e-05	0.000591	CcSEcCtD
Idarubicin—Headache—Methotrexate—bone cancer	1.37e-05	0.000587	CcSEcCtD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.33e-05	0.00336	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NDUFA12—bone cancer	1.3e-05	0.0033	CbGpPWpGaD
Idarubicin—Vomiting—Epirubicin—bone cancer	1.3e-05	0.000558	CcSEcCtD
Idarubicin—Nausea—Methotrexate—bone cancer	1.3e-05	0.000557	CcSEcCtD
Idarubicin—Diarrhoea—Doxorubicin—bone cancer	1.29e-05	0.000555	CcSEcCtD
Idarubicin—Rash—Epirubicin—bone cancer	1.29e-05	0.000553	CcSEcCtD
Idarubicin—Dermatitis—Epirubicin—bone cancer	1.29e-05	0.000553	CcSEcCtD
Idarubicin—Headache—Epirubicin—bone cancer	1.28e-05	0.00055	CcSEcCtD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.28e-05	0.00324	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CHEK2—bone cancer	1.23e-05	0.00312	CbGpPWpGaD
Idarubicin—Nausea—Epirubicin—bone cancer	1.21e-05	0.000521	CcSEcCtD
Idarubicin—Vomiting—Doxorubicin—bone cancer	1.2e-05	0.000516	CcSEcCtD
Idarubicin—Rash—Doxorubicin—bone cancer	1.19e-05	0.000512	CcSEcCtD
Idarubicin—Dermatitis—Doxorubicin—bone cancer	1.19e-05	0.000511	CcSEcCtD
Idarubicin—Headache—Doxorubicin—bone cancer	1.18e-05	0.000509	CcSEcCtD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.15e-05	0.00292	CbGpPWpGaD
Idarubicin—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	1.15e-05	0.00291	CbGpPWpGaD
Idarubicin—Nausea—Doxorubicin—bone cancer	1.12e-05	0.000482	CcSEcCtD
Idarubicin—TOP2A—Circadian rythm related genes—JUN—bone cancer	1.11e-05	0.00281	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NT5C3A—bone cancer	1.08e-05	0.00274	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—BRCA2—bone cancer	1.04e-05	0.00265	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP3A4—bone cancer	9.74e-06	0.00247	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP3A4—bone cancer	9.66e-06	0.00245	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	9.61e-06	0.00243	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	9.52e-06	0.00241	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	9.07e-06	0.0023	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	8.66e-06	0.0022	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—GSTP1—bone cancer	8.33e-06	0.00211	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—GSTP1—bone cancer	8.26e-06	0.00209	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	8.22e-06	0.00208	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	8.15e-06	0.00206	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDK4—bone cancer	7.75e-06	0.00196	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	7.61e-06	0.00193	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	7.53e-06	0.00191	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—TP53—bone cancer	7.31e-06	0.00185	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—RB1—bone cancer	6.74e-06	0.00171	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NDUFA12—bone cancer	5.84e-06	0.00148	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NDUFA12—bone cancer	5.79e-06	0.00147	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MDM2—bone cancer	5.74e-06	0.00146	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ENO2—bone cancer	5.65e-06	0.00143	CbGpPWpGaD
Idarubicin—ABCC1—Disease—DHFR—bone cancer	5.24e-06	0.00133	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NT5C3A—bone cancer	4.84e-06	0.00123	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NT5C3A—bone cancer	4.8e-06	0.00122	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ENO2—bone cancer	4.73e-06	0.0012	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—DHFR—bone cancer	4.39e-06	0.00111	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GNA11—bone cancer	4.1e-06	0.00104	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TGFBR2—bone cancer	3.8e-06	0.000962	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP3A4—bone cancer	3.72e-06	0.000942	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.7e-06	0.000937	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TP53—bone cancer	3.3e-06	0.000835	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTP1—bone cancer	3.18e-06	0.000805	CbGpPWpGaD
Idarubicin—ABCC1—Disease—KIT—bone cancer	2.59e-06	0.000656	CbGpPWpGaD
Idarubicin—ABCC1—Disease—BRAF—bone cancer	2.43e-06	0.000617	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ENO2—bone cancer	2.12e-06	0.000537	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ENO2—bone cancer	2.1e-06	0.000532	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MDM2—bone cancer	2.04e-06	0.000517	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—DHFR—bone cancer	1.97e-06	0.000498	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTGS2—bone cancer	1.97e-06	0.000498	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—DHFR—bone cancer	1.95e-06	0.000494	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GNA11—bone cancer	1.84e-06	0.000466	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GNA11—bone cancer	1.82e-06	0.000462	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP3A4—bone cancer	1.67e-06	0.000422	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP3A4—bone cancer	1.65e-06	0.000419	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS2—bone cancer	1.65e-06	0.000417	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.64e-06	0.000416	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTP1—bone cancer	1.42e-06	0.000361	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTP1—bone cancer	1.41e-06	0.000358	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGFR—bone cancer	1.39e-06	0.000353	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS2—bone cancer	7.38e-07	0.000187	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS2—bone cancer	7.32e-07	0.000185	CbGpPWpGaD
